COMMUNIQUÉS West-GlobeNewswire

BBS-Bioactive Bone Substitutes Plc: Correction to the invitation to annual general meeting of BBS-Bioactive Bone Substitutes Plc published on 15.03.2019 at 12:00 CET
15/03/2019
Correction to the invitation to annual general meeting of BBS-Bioactive Bone Substitutes Plc published on 15.03.2019 at 12:00 CET Participation also requests the shareholder to be temporarily entered into the [...]
Diamond CBD to Showcase Exciting New Product Lines at ASD Market Week
15/03/2019
Popularity of the Company's CBD-infused edibles, oils, and vapes continues to surge ahead of influential Las Vegas trade show for consumer merchandise FT. LAUDERDALE, Fla., March 15, 2019 (GLOBE NEWSWIRE) -- Diamond CBD [...]
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
15/03/2019
WOBURN, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]
Vilacto Bio Canada Patent LACTOACTIVE® Granted
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application [...]
Outlook Therapeutics Announces Reverse Stock Split
15/03/2019
CRANBURY, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”) announced today that its Board of Directors has approved a 1-for-8 reverse stock split of the Company’s common [...]
Helix TCS Expands into Global Markets -- CFN Media
15/03/2019
Seattle, WA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
15/03/2019
PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in vivo wear studies on the [...]
Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
15/03/2019
BEVERLY, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that necessary documentation has [...]
Matrix Medical Network showcases state-of-the-art mobile health clinic at RISE Nashville
15/03/2019
Summit highlights company’s national fleet providing an inside look at the future of population health SCOTTSDALE, Ariz., March 15, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) builds upon last year’s mobile [...]
Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
15/03/2019
Phase 2 head-to-head (COMPARE) clinical trial of SEL-212 vs. KRYSTEXXA® to begin in 1Q19, interim six-month data expected in 4Q19 Collaboration with CureCN projected to dose first patient with combination of ImmTOR + [...]
Extendicare Announces March 2019 Dividend of C$0.04 per Share
15/03/2019
MARKHAM, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results
15/03/2019
LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of [...]
AzurRx BioPharma to Present at the 2019 Annual Roth Capital Conference (March 19) and the Oppenheimer 29th Annual Healthcare Conference (March 20)
15/03/2019
BROOKLYN, N.Y., March 15, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results
15/03/2019
TORONTO and CAMBRIDGE, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting [...]
OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights
15/03/2019
REDWOOD CITY, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (“OncoMed”) (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer [...]
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
15/03/2019
DUBLIN, Ireland, March 15, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced its financial results for the fourth quarter and [...]
Oncology Venture receives guarantees and undertakings for a proposed rights issue
15/03/2019
Press release Hoersholm, Denmark, March 15, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces that its Board of Directors proposes a rights issue of SEK 60-100 million at the coming [...]

Pages